Why Moderna Stock Jumped Today
Published
A coronavirus vaccine authorization, a new partnership, and a bullish revenue forecast have investors excited.
Full ArticlePublished
A coronavirus vaccine authorization, a new partnership, and a bullish revenue forecast have investors excited.
Full ArticleWith a competitor stumbling, the biotech could see increased demand for its COVID-19 vaccine.